doi: 10.3389/fimmu.2025.1610368 Received 11 April 2025 Accepted 26 June 2025 Published 15 July 2025 Volume 16 - 2025 Edited by Li-Tung Huang, Kaohsiung Chang Gung Memorial Hospital, Taiwan Reviewed by Beata Kasztelan-Szczerbinska, Medical University of Lublin, Poland Edit Posta, University of Debrecen, Hungary Updates Copyright 2025 Migliorisi, Gabbiadini, Dal Buono, Ferraris, Privitera, Petronio, Bertoli, Bezzio and Armuzzi
Sometimes, facial appearance might improve after stopping semaglutide, as Conclusion As youve learned, the rapid weight loss caused by Ozempic and other GLP-1 receptor agonists can lead to unwanted facial changes referred to on social media as Ozempic face
and preterm delivery (RR = 1.34
Semaglutide is administered as a once-weekly subcutaneous injection (a small needle just under the skin most patients say they barely feel it)
New Noom
Diabetes Obesity Metab